Renal Health Improvement in Diabetes through Microbiome Modulation of the Gut–Kidney Axis with Biotics: A Systematic and Narrative Review of Randomized Controlled Trials

Diabetes mellitus is the most common endocrine disorder worldwide, with over 20% of patients ultimately developing diabetic kidney disease (DKD), a complex nephropathic complication that is a leading cause of end-stage renal disease. Various clinical trials have utilized probiotics, prebiotics, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Pradipta, Kaul, Ridhima, Chaari, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740604/
https://www.ncbi.nlm.nih.gov/pubmed/36499168
http://dx.doi.org/10.3390/ijms232314838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740604/
https://www.ncbi.nlm.nih.gov/pubmed/36499168
http://dx.doi.org/10.3390/ijms232314838

Ejemplares similares